DigitalHealth InvestorTalk Show · 2026-01-29 · 1h 22m
What's next for funded companies with growth issues? After the euphoria of the Zero Interest Rate Period (ZIRP) when many companies received significant funding at high valuations, reality has set in for many of those companies. Slower than expected growth, missed milestones, and a more selective funding environment are forcing tough choices on the management teams of these companies. In this show we'll cover: The changing opportunities and challenges for digital health companies The investors' perspectives The range of strategic alternatives available to companies And we'll answer your questions. Ron Razmi, MD , is the Managing Director of Zoi, a health AI advisory and investment firm, and the author of AI Doctor: The Rise of Artificial Intelligence in Healthcare . A cardiologist by training, he was previously a McKinsey consultant and CEO of health technology company. He currently writes a column for Fast Company and the The AI Doctor Blog on substack, and comments regularly on CNBC , Fox Business , and other media outlets on the health economy.
The Future of Digital Therapeutics with Eddie Martucci and Steven Wardell74 / 100Here Comes Telehealth 2.0 with Dr. Lyle Berkowitz and Steven WardellConsolidation in Employer HealthTech with Chris Michalak and Steven WardellFrom GenAI to Patient Agency with David Shaywitz and Steven WardellWhat's Happening at ViVE in February? With Adam Kaufman and Steven Wardell